
Tirzepatide
Tirzepatide is a novel dual agonist peptide that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By increasing insulin availability and decreasing glucagon activity, tirzepatide supports glucose regulation and metabolic function.
Interest in tirzepatide has grown because of its role in appetite regulation, satiety, gastric emptying, and overall metabolic support. As part of a provider-guided approach, tirzepatide may be considered within broader weight-loss and metabolic optimization strategies.
Choose options



How It Works
Why People Are Interested
Benefits
Who Can Benefit
Why Evaluation Matters
Treatment Process
Every program at Evolve follows a structured clinical model:
Comprehensive testing reveals your current physiology
Patterns, imbalances, and risk markers are identified
Treatment is selected based on objective data
Ongoing testing ensures safety and effectiveness
Schedule a Peptide Consultation
Discuss whether this approach may be appropriate as part of your personalized care plan.
